APA

Abbruzzese J. L., Levin B., Ajani J. A., Faintuch J. S., Pazdur R., Saks S., Edwards C. & Gutterman J. U. (19910118). A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity. : Journal of biological response modifiers.

Chicago

Abbruzzese J L, Levin B, Ajani J A, Faintuch J S, Pazdur R, Saks S, Edwards C and Gutterman J U. 19910118. A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity. : Journal of biological response modifiers.

Harvard

Abbruzzese J. L., Levin B., Ajani J. A., Faintuch J. S., Pazdur R., Saks S., Edwards C. and Gutterman J. U. (19910118). A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity. : Journal of biological response modifiers.

MLA

Abbruzzese J L, Levin B, Ajani J A, Faintuch J S, Pazdur R, Saks S, Edwards C and Gutterman J U. A phase II trial of recombinant human interferon-gamma and recombinant tumor necrosis factor in patients with advanced gastrointestinal malignancies: results of a trial terminated by excessive toxicity. : Journal of biological response modifiers. 19910118.